{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:03:37Z","timestamp":1790035417235,"version":"4.0.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-65972-w","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T12:04:18Z","timestamp":1765195458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Predictive models of melanoma metastasis based on dermatoscopy in an international retrospective human reader study"],"prefix":"10.1038","volume":"16","author":[{"given":"Konstantinos","family":"Lallas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0051-8016","authenticated-orcid":false,"given":"Harald","family":"Kittler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0391-7810","authenticated-orcid":false,"given":"Philipp","family":"Tschandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Liopyris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1413-8214","authenticated-orcid":false,"given":"Giuseppe","family":"Argenziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato Marchiori","family":"Bakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horacio","family":"Cabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3186-2861","authenticated-orcid":false,"given":"Emi","family":"Dika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6998-914X","authenticated-orcid":false,"given":"Josep","family":"Malvehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6068-0114","authenticated-orcid":false,"given":"Ashfaq","family":"Marghoob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1337-9745","authenticated-orcid":false,"given":"Susana","family":"Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon","family":"Scope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4515-9395","authenticated-orcid":false,"given":"Wilhelm","family":"Stolz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akane","family":"Minagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela Martins","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Agozzino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Shalmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Briatico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia Noemi","family":"Cohen Sabban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9423-3435","authenticated-orcid":false,"given":"Victoria","family":"Mar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Mahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6294-4109","authenticated-orcid":false,"given":"Nicholas M.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8034-9856","authenticated-orcid":false,"given":"Timothy","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7855-4930","authenticated-orcid":false,"given":"Felix","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Alessandrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Chamberlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Vico-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1995-2434","authenticated-orcid":false,"given":"Luc","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4770-561X","authenticated-orcid":false,"given":"H. Peter","family":"Soyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Apalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstrations","family":"Vakirlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Zalaudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7193-0964","authenticated-orcid":false,"given":"Aimilios","family":"Lallas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"65972_CR1","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1080\/14737140.2018.1489246","volume":"18","author":"EZ Keung","year":"2018","unstructured":"Keung, E. Z. & Gershenwald, J. E. The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care. Expert Rev. Anticancer Ther. 18, 775\u2013784 (2018).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"65972_CR2","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1038\/s41591-023-02583-2","volume":"29","author":"JM Kirkwood","year":"2023","unstructured":"Kirkwood, J. M. et al. Adjuvant nivolumab in resected stage IIB\/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial. Nat. Med 29, 2835\u20132843 (2023).","journal-title":"Nat. Med"},{"key":"65972_CR3","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1016\/S0140-6736(22)00562-1","volume":"399","author":"JJ Luke","year":"2022","unstructured":"Luke, J. J. et al. Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial. Lancet 399, 1718\u20131729 (2022).","journal-title":"Lancet"},{"key":"65972_CR4","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/jid.2014.452","volume":"135","author":"DC Whiteman","year":"2015","unstructured":"Whiteman, D. C., Baade, P. D. & Olsen, C. M. More people die from thin melanomas (\u2a7d1\u2009mm) than from thick melanomas (>4\u2009mm) in Queensland, Australia. J. Invest Dermatol 135, 1190\u20131193 (2015).","journal-title":"J. Invest Dermatol"},{"key":"65972_CR5","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1200\/JCO.22.00202","volume":"40","author":"C Garbe","year":"2022","unstructured":"Garbe, C. et al. Prognosis of patients with primary melanoma Stage I and II According to American Joint Committee on Cancer Version 8 validated in two independent cohorts: implications for adjuvant treatment. J. Clin. Oncol. 40, 3741\u20133749 (2022).","journal-title":"J. Clin. Oncol."},{"key":"65972_CR6","doi-asserted-by":"publisher","first-page":"104458","DOI":"10.1016\/j.critrevonc.2024.104458","volume":"202","author":"K Lallas","year":"2024","unstructured":"Lallas, K. et al. Clinical, dermatoscopic, histological and molecular predictive factors of distant melanoma metastasis: a systematic review and meta-analysis. Crit. Rev. Oncol.\/Hematol. 202, 104458 (2024).","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"65972_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejca.2020.04.022","volume":"134","author":"D Verver","year":"2020","unstructured":"Verver, D. et al. The EORTC-DeCOG nomogram adequately predicts outcomes of patients with sentinel node\u2013positive melanoma without the need for completion lymph node dissection. Eur. J. Cancer 134, 9\u201318 (2020).","journal-title":"Eur. J. Cancer"},{"key":"65972_CR8","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1200\/JCO.20.02446","volume":"39","author":"MA El Sharouni","year":"2021","unstructured":"El Sharouni, M. A. et al. Development and Validation of Nomograms to Predict Local, Regional, and Distant Recurrence in Patients With Thin (T1) Melanomas. J. Clin. Oncol. 39, 1243\u20131252 (2021).","journal-title":"J. Clin. Oncol."},{"key":"65972_CR9","doi-asserted-by":"crossref","unstructured":"Dixon, A. J. et al. BAUSSS biomarker further validated as a key risk staging tool for patients with primary melanoma. J. Eur. Acad. Dermatol. Venereol. 39, 779\u2013781 (2024).","DOI":"10.1111\/jdv.19889"},{"key":"65972_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ejca.2022.12.021","volume":"182","author":"T Amaral","year":"2023","unstructured":"Amaral, T. et al. Identification of stage I\/II melanoma patients at high risk for recurrence using a model combining clinicopathologic factors with gene expression profiling (CP-GEP). Eur. J. Cancer 182, 155\u2013162 (2023).","journal-title":"Eur. J. Cancer"},{"key":"65972_CR11","doi-asserted-by":"crossref","unstructured":"Mulder, E. et al. Using a clinicopathologic and gene expression (CP-GEP) model to identify stage I-II melanoma patients at risk of disease relapse. Cancers 14, 2854 (2022).","DOI":"10.3390\/cancers14122854"},{"key":"65972_CR12","doi-asserted-by":"crossref","unstructured":"Hsueh, E. C. et al. Long-term outcomes in a multicenter, prospective cohort evaluating the prognostic 31-gene expression profile for cutaneous melanoma. JCO Precis. Oncol. 5, 119 (2021).","DOI":"10.1200\/PO.20.00119"},{"key":"65972_CR13","first-page":"Cd011902","volume":"12","author":"J Dinnes","year":"2018","unstructured":"Dinnes, J. et al. Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults. Cochrane Database Syst. Rev. 12, Cd011902 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"65972_CR14","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.clindermatol.2013.05.003","volume":"31","author":"Z Apalla","year":"2013","unstructured":"Apalla, Z. et al. The light and the dark of dermatoscopy in the early diagnosis of melanoma: Facts and controversies. Clin. Dermatol. 31, 671\u2013676 (2013).","journal-title":"Clin. Dermatol."},{"key":"65972_CR15","first-page":"274","volume":"156","author":"A Lallas","year":"2021","unstructured":"Lallas, A. et al. Dermatoscopy of melanoma according to type, anatomic site and stage. Ital. J. Dermatol Venerol. 156, 274\u2013288 (2021).","journal-title":"Ital. J. Dermatol Venerol."},{"key":"65972_CR16","doi-asserted-by":"crossref","unstructured":"Filipovi\u0107, N., \u0160itum, M. & Buljan, M. Dermoscopic features as predictors of BRAF mutational status and sentinel lymph node positivity in primary cutaneous melanoma. Dermatol. Pract. Concep. 11, e2021040 (2021).","DOI":"10.5826\/dpc.1102a40"},{"key":"65972_CR17","doi-asserted-by":"crossref","unstructured":"De Giorgi, V. et al. Dermoscopy as a tool for identifying potentially metastatic thin melanoma: a clinical-dermoscopic and histopathological case-control study. Cancers 16, 1394 (2024).","DOI":"10.3390\/cancers16071394"},{"key":"65972_CR18","doi-asserted-by":"publisher","first-page":"e0174871","DOI":"10.1371\/journal.pone.0174871","volume":"12","author":"T Deinlein","year":"2017","unstructured":"Deinlein, T. et al. Dermoscopic characteristics of melanoma according to the criteria \u201culceration\u201d and \u201cmitotic rate\u201d of the AJCC 2009 staging system for melanoma. PLoS One 12, e0174871 (2017).","journal-title":"PLoS One"},{"key":"65972_CR19","doi-asserted-by":"crossref","unstructured":"Saud, A., Sagineedu, S. R., Ng, H. S., Stanslas, J. & Lim, J. C. W. Melanoma metastasis: what role does melanin play? (Review). Oncol Rep 48, 217 (2022).","DOI":"10.3892\/or.2022.8432"},{"key":"65972_CR20","doi-asserted-by":"publisher","first-page":"9280","DOI":"10.1038\/s41598-019-45643-9","volume":"9","author":"M Sarna","year":"2019","unstructured":"Sarna, M., Krzykawska-Serda, M., Jakubowska, M., Zadlo, A. & Urbanska, K. Melanin presence inhibits melanoma cell spread in mice in a unique mechanical fashion. Sci. Rep. 9, 9280 (2019).","journal-title":"Sci. Rep."},{"key":"65972_CR21","doi-asserted-by":"publisher","first-page":"887366","DOI":"10.3389\/fonc.2022.887366","volume":"12","author":"LC Caba\u00e7o","year":"2022","unstructured":"Caba\u00e7o, L. C., Tom\u00e1s, A., Pojo, M. & Barral, D. C. The Dark Side of Melanin Secretion in Cutaneous Melanoma Aggressiveness. Front Oncol. 12, 887366 (2022).","journal-title":"Front Oncol."},{"key":"65972_CR22","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ccell.2018.03.017","volume":"33","author":"J Tsoi","year":"2018","unstructured":"Tsoi, J. et al. Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress. Cancer Cell 33, 890\u2013904.e895 (2018).","journal-title":"Cancer Cell"},{"key":"65972_CR23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cell.2023.11.037","volume":"187","author":"J Pozniak","year":"2024","unstructured":"Pozniak, J. et al. A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma. Cell 187, 166\u2013183.e125 (2024).","journal-title":"Cell"},{"key":"65972_CR24","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/cancers3010126","volume":"3","author":"WE Damsky","year":"2010","unstructured":"Damsky, W. E., Rosenbaum, L. E. & Bosenberg, M. Decoding melanoma metastasis. Cancers 3, 126\u2013163 (2010).","journal-title":"Cancers"},{"key":"65972_CR25","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1177\/107327489500200503","volume":"2","author":"IJ Fiddler","year":"1995","unstructured":"Fiddler, I. J. Melanoma metastasis. Cancer Control 2, 398\u2013404 (1995).","journal-title":"Cancer Control"},{"key":"65972_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0190-9622(92)70146-7","volume":"27","author":"DG Brodland","year":"1992","unstructured":"Brodland, D. G. & Zitelli, J. A. Mechanisms of metastasis. J. Am. Acad. Dermatol 27, 1\u20138 (1992).","journal-title":"J. Am. Acad. Dermatol"},{"key":"65972_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1046\/j.1087-0024.2000.00001.x","volume":"5","author":"M Skobe","year":"2000","unstructured":"Skobe, M. & Detmar, M. Structure, function, and molecular control of the skin lymphatic system. J. Investig. Dermatol Symp. Proc. 5, 14\u201319 (2000).","journal-title":"J. Investig. Dermatol Symp. Proc."},{"key":"65972_CR28","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.3892\/ol.2016.4813","volume":"12","author":"R Betti","year":"2016","unstructured":"Betti, R., Agape, E., Vergani, R., Moneghini, L. & Cerri, A. An observational study regarding the rate of growth in vertical and radial growth phase superficial spreading melanomas. Oncol. Lett. 12, 2099\u20132102 (2016).","journal-title":"Oncol. Lett."},{"key":"65972_CR29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1098\/rsif.2010.0285","volume":"8","author":"P Ciarletta","year":"2011","unstructured":"Ciarletta, P., Foret, L. & Ben Amar, M. The radial growth phase of malignant melanoma: multi-phase modelling, numerical simulations and linear stability analysis. J. R. Soc. Interface 8, 345\u2013368 (2011).","journal-title":"J. R. Soc. Interface"},{"key":"65972_CR30","doi-asserted-by":"publisher","first-page":"342s","DOI":"10.1038\/jid.1993.60","volume":"100","author":"DT Guerry","year":"1993","unstructured":"Guerry, D. T., Synnestvedt, M., Elder, D. E. & Schultz, D. Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent. J. Invest Dermatol 100, 342s\u2013345s (1993).","journal-title":"J. Invest Dermatol"},{"key":"65972_CR31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10555-021-09960-8","volume":"40","author":"HH Vandyck","year":"2021","unstructured":"Vandyck, H. H. et al. Rethinking the biology of metastatic melanoma: a holistic approach. Cancer Metastasis Rev. 40, 603\u2013624 (2021).","journal-title":"Cancer Metastasis Rev."},{"key":"65972_CR32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/bjd.13861","volume":"173","author":"MA Pizzichetta","year":"2015","unstructured":"Pizzichetta, M. A. et al. Pigmented nodular melanoma: the predictive value of dermoscopic features using multivariate analysis. Br. J. Dermatol. 173, 106\u2013114 (2015).","journal-title":"Br. J. Dermatol."},{"key":"65972_CR33","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1111\/jdv.19221","volume":"37","author":"C Longo","year":"2023","unstructured":"Longo, C. et al. Dermoscopy of melanoma according to different body sites: Head and neck, trunk, limbs, nail, mucosal and acral. J. Eur. Acad. Dermatol. Venereol. 37, 1718\u20131730 (2023).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"65972_CR34","doi-asserted-by":"crossref","unstructured":"Massone, C., Hofman-Wellenhof, R., Chiodi, S. & Sola, S. Dermoscopic criteria, histopathological correlates and genetic findings of thin melanoma on non-volar skin. Genes 12, 1288 (2021).","DOI":"10.3390\/genes12081288"},{"key":"65972_CR35","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.2147\/CCID.S372287","volume":"15","author":"Z Barricklow","year":"2022","unstructured":"Barricklow, Z., DiVincenzo, M. J., Angell, C. D. & Carson, W. E. Ulcerated cutaneous melanoma: a review of the clinical, histologic, and molecular features associated with a clinically aggressive histologic phenotype. Clin. Cosmet. Investig. Dermatol 15, 1743\u20131757 (2022).","journal-title":"Clin. Cosmet. Investig. Dermatol"},{"key":"65972_CR36","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1309\/AJCPW56PHGLFTKZC","volume":"142","author":"ML B\u00f8nnelykke-Behrndtz","year":"2014","unstructured":"B\u00f8nnelykke-Behrndtz, M. L. et al. Prognostic stratification of ulcerated melanoma: not only the extent matters. Am. J. Clin. Pathol. 142, 845\u2013856 (2014).","journal-title":"Am. J. Clin. Pathol."},{"key":"65972_CR37","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1097\/SLA.0b013e31824c4b0b","volume":"255","author":"FE In \u2018t Hout","year":"2012","unstructured":"In \u2018t Hout, F. E. et al. Prognostic importance of the extent of ulceration in patients with clinically localized cutaneous melanoma. Ann. Surg. 255, 1165\u20131170 (2012).","journal-title":"Ann. Surg."},{"key":"65972_CR38","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jaad.2018.07.073","volume":"80","author":"O Y\u00e9lamos","year":"2019","unstructured":"Y\u00e9lamos, O. et al. Dermoscopy and dermatopathology correlates of cutaneous neoplasms. J. Am. Acad. Dermatol 80, 341\u2013363 (2019).","journal-title":"J. Am. Acad. Dermatol"},{"key":"65972_CR39","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1001\/jamadermatol.2017.6447","volume":"154","author":"A Lallas","year":"2018","unstructured":"Lallas, A. et al. Accuracy of dermoscopic criteria for the diagnosis of melanoma in situ. JAMA Dermatol 154, 414\u2013419 (2018).","journal-title":"JAMA Dermatol"},{"key":"65972_CR40","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1111\/jdv.18436","volume":"36","author":"S Polesie","year":"2022","unstructured":"Polesie, S. et al. Assessment of melanoma thickness based on dermoscopy images: an open, web-based, international, diagnostic study. J. Eur. Acad. Dermatol Venereol. 36, 2002\u20132007 (2022).","journal-title":"J. Eur. Acad. Dermatol Venereol."},{"key":"65972_CR41","first-page":"2939","volume":"27","author":"G Pagnanelli","year":"2007","unstructured":"Pagnanelli, G. et al. Clinical and dermoscopic criteria related to melanoma sentinel lymph node positivity. Anticancer Res. 27, 2939\u20132944 (2007).","journal-title":"Anticancer Res."},{"key":"65972_CR42","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1038\/s41379-021-00870-2","volume":"34","author":"K Aivazian","year":"2021","unstructured":"Aivazian, K. et al. Histological regression in melanoma: impact on sentinel lymph node status and survival. Mod. Pathol. 34, 1999\u20132008 (2021).","journal-title":"Mod. Pathol."},{"key":"65972_CR43","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1001\/jamadermatol.2015.2235","volume":"151","author":"S Ribero","year":"2015","unstructured":"Ribero, S. et al. Association of histologic regression in primary melanoma with sentinel lymph node status: a systematic review and meta-analysis. JAMA Dermatol 151, 1301\u20131307 (2015).","journal-title":"JAMA Dermatol"},{"key":"65972_CR44","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1200\/JCO.2013.54.2340","volume":"32","author":"A Maurichi","year":"2014","unstructured":"Maurichi, A. et al. Prediction of survival in patients with thin melanoma: results from a multi-institution study. J. Clin. Oncol. 32, 2479\u20132485 (2014).","journal-title":"J. Clin. Oncol."},{"key":"65972_CR45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/jso.26678","volume":"125","author":"S Subramanian","year":"2022","unstructured":"Subramanian, S. et al. Regression in melanoma is significantly associated with a lower regional recurrence rate and better recurrence-free survival. J. Surg. Oncol. 125, 229\u2013238 (2022).","journal-title":"J. Surg. Oncol."},{"key":"65972_CR46","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/bjd.15552","volume":"178","author":"MR Gualano","year":"2018","unstructured":"Gualano, M. R. et al. Prognostic role of histological regression in primary cutaneous melanoma: a systematic review and meta-analysis. Br. J. Dermatol 178, 357\u2013362 (2018).","journal-title":"Br. J. Dermatol"},{"key":"65972_CR47","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.jaad.2023.11.040","volume":"90","author":"NB Wagner","year":"2024","unstructured":"Wagner, N. B. et al. Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: a single-institutional cohort study. J. Am. Acad. Dermatol 90, 739\u2013748 (2024).","journal-title":"J. Am. Acad. Dermatol"},{"key":"65972_CR48","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1600-0560.2006.00681.x","volume":"34","author":"T Handerson","year":"2007","unstructured":"Handerson, T. et al. Melanophages reside in hypermelanotic, aberrantly glycosylated tumor areas and predict improved outcome in primary cutaneous malignant melanoma. J. Cutan. Pathol. 34, 679\u2013686 (2007).","journal-title":"J. Cutan. Pathol."},{"key":"65972_CR49","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1111\/jdv.16815","volume":"34","author":"D Sgouros","year":"2020","unstructured":"Sgouros, D. et al. Dermatoscopic features of thin (\u22642 mm Breslow thickness) vs. thick (>2 mm Breslow thickness) nodular melanoma and predictors of nodular melanoma versus nodular non-melanoma tumours: a multicentric collaborative study by the International Dermoscopy Society. J. Eur. Acad. Dermatol Venereol. 34, 2541\u20132547 (2020).","journal-title":"J. Eur. Acad. Dermatol Venereol."},{"key":"65972_CR50","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jaad.2017.12.064","volume":"78","author":"M Armengot-Carb\u00f3","year":"2018","unstructured":"Armengot-Carb\u00f3, M., Nagore, E., Garc\u00eda-Casado, Z. & Botella-Estrada, R. The association between dermoscopic features and BRAF mutational status in cutaneous melanoma: significance of the blue-white veil. J. Am. Acad. Dermatol 78, 920\u2013926 (2018).","journal-title":"J. Am. Acad. Dermatol"},{"key":"65972_CR51","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/bjd\/ljae281","volume":"191","author":"K Lallas","year":"2024","unstructured":"Lallas, K. et al. Prediction of melanoma metastasis using dermatoscopy deep features: an international multicentre cohort study. Br. J. Dermatol 191, 847\u2013848 (2024).","journal-title":"Br. J. Dermatol"},{"key":"65972_CR52","doi-asserted-by":"publisher","first-page":"112914","DOI":"10.1016\/j.ejca.2023.05.003","volume":"189","author":"R Lee","year":"2023","unstructured":"Lee, R. et al. Adjuvant therapy for stage II melanoma: the need for further studies. Eur. J. Cancer 189, 112914 (2023).","journal-title":"Eur. J. Cancer"},{"key":"65972_CR53","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1056\/NEJMoa2402604","volume":"391","author":"CU Blank","year":"2024","unstructured":"Blank, C. U. et al. Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma. N. Engl. J. Med. 391, 1696\u20131708 (2024).","journal-title":"N. Engl. J. Med."},{"key":"65972_CR54","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1056\/NEJMoa2211437","volume":"388","author":"SP Patel","year":"2023","unstructured":"Patel, S. P. et al. Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma. N. Engl. J. Med. 388, 813\u2013823 (2023).","journal-title":"N. Engl. J. Med."},{"key":"65972_CR55","doi-asserted-by":"publisher","first-page":"e32955","DOI":"10.1371\/journal.pone.0032955","volume":"7","author":"L Mervic","year":"2012","unstructured":"Mervic, L. Time course and pattern of metastasis of cutaneous melanoma differ between men and women. PLoS One 7, e32955 (2012).","journal-title":"PLoS One"},{"key":"65972_CR56","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1046\/j.1365-2133.2002.04867.x","volume":"147","author":"F Meier","year":"2002","unstructured":"Meier, F. et al. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br. J. Dermatol 147, 62\u201370 (2002).","journal-title":"Br. J. Dermatol"},{"key":"65972_CR57","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis, J. R. & Koch, G. G. The measurement of observer agreement for categorical data. Biometrics 33, 159\u2013174 (1977).","journal-title":"Biometrics"},{"key":"65972_CR58","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong, E. R., DeLong, D. M. & Clarke-Pearson, D. L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44, 837\u2013845 (1988).","journal-title":"Biometrics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65972-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65972-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65972-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:04:22Z","timestamp":1765584262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65972-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["65972"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-65972-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"TA- TA reports personal fees for advisory board membership from Delcath and Philogen; personal fees as an invited speaker from Bristol Myers Squibb (BMS), Medscape, Neracare, Novartis and Pierre Fabre; personal fees for a writing engagement from CeCaVa and Medtrix; institutional fees as local principal investigator (PI) from Agenus Inc., AstraZeneca, BioNTech, BMS, HUYA Bioscience, Immunocore, IO Biotech, MSD, Pfizer, Philogen, Regeneron, Roche and University Hospital Essen; institutional fees as coordinating PI from Unicancer; institutional research grants from iFIT and Novartis; institutional funding from MNI - Naturwissenschaftliches und Medizinisches Institut, Neracare, Novartis, Pascoe, Sanofi and Skyline-Dx; non-remunerated membership of the American Society of Clinical Oncology (ASCO) and the Portuguese Society for Medical Oncology; a role as clinical expert in the area of medical oncology for Infarmed, and a role as an expert for SGA-Oncology at EMA. These activities had no role in the study\u2019s design, data acquisition, results interpretation and decision to submit. HPS- HPS is a shareholder of MoleMap NZ Limited and e-derm consult. GmbH and undertakes regular teledermatological reporting for both companies. HPS is a Medical Consultant for Canfield Scientific Inc and a Medical Advisor for First Derm. These activities had no role in the study\u2019s design, data acquisition, results interpretation and decision to submit. All remaining authors have declared no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10940"}}